Drug
Mcla 145
Mcla 145: highest development phase Phase 1, developed by Merus. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Merus
Trials
| Drug | Phase | Indication |
|---|---|---|
| MCLA-145 NCT03922204 | Phase 1 | Advanced Cancer |
Latest
No recent events.
Follow Mcla 145 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.